French digital platform for early/post-MA access applications

SÉSAME is the official HAS digital platform for submitting early (AP1) and post-MA (AP2) access applications.

It centralises exchanges between pharmaceutical companies and health authorities, streamlining submission tracking and validation. SÉSAME harmonises procedures and shortens review times for patient access to innovative medicines.